Glennj Hanna News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant

Two studies had 'important differences,' but can help guide clinicians

United statesDana farber cancer instituteEvanj lipsonMike bassettShlomoa koyfmanJessical geigerGlennj hannaJohns hopkins university school of medicineClinical oncologyJohns hopkins university schoolCleveland clinicClin oncol

FDA Approval Insights: Toripalimab in Recurrent/Metastatic Nasopharyngeal Carcinoma

Drs Hanna and Kandula discuss the significance of the FDA approval of toripalimab in nasopharyngeal carcinoma; pivotal data from the JUPITER-02 and POLARIS-02 trials; and how this regulatory decision increases the importance of multidisciplinary collaboration.

Dana farber cancer instituteUnited statesShravan kandulaAshling wahnerGlennj hannaHarvard medical schoolCancer therapeutic innovation early drug development programLive on airCancer therapeutic innovationEarly drug development programRare headNeck cancersAdventhealth medical group radiation oncologyCentral floridaDrs hannaOnclive on air

Dr Hanna on the FDA Approval of Toripalimab in Nasopharyngeal Carcinoma

Glenn J. Hanna, MD, discusses the significance of the FDA approval of toripalimab for patients with recurrent or metastatic nasopharyngeal carcinoma.

United statesGlennj hannaDana farber cancer instituteCancer therapeutic innovation early drug development programHarvard medical schoolCancer therapeutic innovationEarly drug development programRare headNeck cancersFda approval of toripalimabPatients with recurrent or metastatic nasopharyngeal carcinoma

Naveris Announces Two Peer-Review Publications Validating NavDx® Performance in Daily Clinical Practice

Naveris Announces Two Peer-Review Publications Validating NavDx® Performance in Daily Clinical Practice
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDana farber cancer instituteNorth carolinaMegan kernanPiyushb guptaGlennj hannaNaveris incYork state department of health wadsworth centerCollege of american pathologistsClinical cancer researchDrug administrationNeck surgeryPredictive valueCirculating tumor tissue modified viralOropharyngeal cancer surveillanceCancer therapeutic innovation

ImmunityBio (IBRX) Says Phase 1 Study Indicates Allogeneic CIML NK Cells Plus N-803 May Induce Tumor Regression in Advanced Head-and-Neck Cancer Patients

ImmunityBio (IBRX) Says Phase 1 Study Indicates Allogeneic CIML NK Cells Plus N-803 May Induce Tumor Regression in Advanced Head-and-Neck Cancer Patients
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesGlennj hannaImmunitybio incNeck societyDana farber cancer instituteProfessor of medicine at harvard medical schoolAmerican association for cancer researchMedical oncologistAssistant professorHarvard medical schoolAmerican associationCancer researchAmerican headPatrick soon shiongExecutive chairmanGlobal chief scientific